This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy
Leukemia Open Access 08 June 2022
-
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network
Journal of Cancer Research and Clinical Oncology Open Access 07 March 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gillert E, Leis T, Repp R, Reichel M, Hosch A, Breitenlohner I et al. A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells. Oncogene 1999; 18: 4663–4671.
Reiter A, Saussele S, Grimwade D, Wiemels JL, Segal MR, Lafage-Pochitaloff M et al. Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia. Genes Chromosomes Cancer 2003; 36: 175–188.
Zhang JG, Goldman JM, Cross NC . Characterization of genomic BCR-ABL breakpoints in chronic myeloid leukaemia by PCR. Br J Haematol 1995; 90: 138–146.
Mattarucchi E, Guerini V, Rambaldi A, Campiotti L, Venco A, Pasquali F et al. Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia. Genes Chromosomes Cancer 2008; 47: 625–632.
Jeffs AR, Benjes SM, Smith TL, Sowerby SJ, Morris CM . The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia. Hum Mol Genet 1998; 7: 767–776.
Krumbholz M, Karl M, Tauer JT, Thiede C, Rascher W, Suttorp M et al. Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia. Genes Chromosomes Cancer 2012; 51: 1045–1053.
Score J, Calasanz MJ, Ottman O, Pane F, Yeh RF, Sobrinho-Simoes MA et al. Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formation. Leukemia 2010; 24: 1742–1750.
Bartley PA, Martin-Harris MH, Budgen BJ, Ross DM, Morley AA . Rapid isolation of translocation breakpoints in chronic myeloid and acute promyelocytic leukaemia. Br J Haematol 2010; 149: 231–236.
Sobrinho-Simoes M, Wilczek V, Score J, Cross NC, Apperley JF, Melo JV . In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinib. Blood 2010; 116: 1329–1335.
Ross DM, Schafranek L, Hughes TP, Nicola M, Branford S, Score J . Genomic translocation breakpoint sequences are conserved in BCR-ABL1 cell lines despite the presence of amplification. Cancer Genet Cytogenet 2009; 189: 138–139.
Rahman M, Pearson LM, Heien HCA . Modified Anderson-Darling Test for Uniformity. Bull Malays Math Sci Soc 2006; 29: 11–16.
Bailey TL, Boden M, Buske FA, Frith M, Grant CE, Clementi L et al. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res 2009; 37: W202–W208.
Kato T, Inagaki H, Kogo H, Ohye T, Yamada K, Emanuel BS et al. Two different forms of palindrome resolution in the human genome: deletion or translocation. Hum Mol Genet 2008; 17: 1184–1191.
Saglio G, Storlazzi CT, Giugliano E, Surace C, Anelli L, Rege-Cambrin G et al. A 76-kb duplicon maps close to the BCR gene on chromosome 22 and the ABL gene on chromosome 9: possible involvement in the genesis of the Philadelphia chromosome translocation. Proc Natl Acad Sci USA 2002; 99: 9882–9887.
Ross DM, Branford S, Seymour JF, Schwarer AP, Arthur C, Bartley PA et al. Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR. Leukemia 2010; 24: 1719–1724.
Acknowledgements
DMR was supported by a Leukaemia Foundation of Australia Scholarship. This study was supported in part by research funding from Novartis to DMR and TPH. Additional samples were provided by the Australasian Leukaemia and Lymphoma Group Tissue Bank.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Ross, D., O'Hely, M., Bartley, P. et al. Distribution of genomic breakpoints in chronic myeloid leukemia: analysis of 308 patients. Leukemia 27, 2105–2107 (2013). https://doi.org/10.1038/leu.2013.116
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2013.116
This article is cited by
-
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy
Leukemia (2022)
-
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network
Journal of Cancer Research and Clinical Oncology (2021)
-
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells
Leukemia (2018)